Exploring how non-COPD medications can improve COPD management
Official title: Evaluating the Impact of Non-COPD Medications on COPD Management
Funded at Brigham and Women's Hospital · NIH-10944383 · Data updated 2026-11-12
This study is looking at whether some medications that aren't originally meant for COPD can help improve the treatment of COPD for patients, using health records to find out which ones might work best.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 17, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $794,681 |
| NIH project number | 1R01HL174838-01 |
| Project ID | NIH-10944383 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who may benefit from alternative medication options.
✕Less likely to help
Patients with COPD who are already receiving optimal treatment or those with other unrelated health conditions may not benefit from this research.
What this research studies
This research investigates the potential of repurposing existing non-COPD medications to enhance the management of chronic obstructive pulmonary disease (COPD). By utilizing electronic health records and claims data, the study aims to identify effective drug options that could benefit COPD patients. The approach involves analyzing a large dataset of U.S. patients, including those with Medicare and commercial insurance, to evaluate the outcomes of these medications on COPD severity and management. The goal is to create a robust analytics infrastructure that can lead to new therapeutic strategies for COPD.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for COPD patients, improving their quality of life and disease management.
How similar studies have gone: Previous research has shown promise in repurposing existing medications for various conditions, suggesting that this approach could yield beneficial results for COPD as well.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Bykov, Katsiaryna — Brigham and Women's Hospital
- Study coordinator: Bykov, Katsiaryna
Related research
Other NIH-funded projects on the same topics.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Clinical CT Imaging to identify and subtype pulmonary hypertension in COPD
A new CT imaging approach aims to help doctors detect and classify pulmonary hypertension in people with COPD.
-
Next-Generation Wearable AI for Precision COPD Risk and Care
A patient-centered project uses a smart wearable and AI to predict COPD flare-ups and support doctors in making better care decisions.
-
Ethics-aware Multimodal AI for COPD prevention, diagnosis, and treatment
A broad AI model uses diverse health data to help predict and manage COPD in people, with an emphasis on ethics and fairness.
-
Easier, local pulmonary rehab and social support for people with COPD in low-resource clinics
This project compares a 10-week community pulmonary rehabilitation program alone, the same program plus help with social needs, and usual care for people with moderate-to-severe COPD to see which helps people stick with rehab and feel better.
-
Improving COPD outcomes with real-world data
A doctor-scientist at a major university is using real-world information from COPD patients to understand which treatments work best, how safe they are, and whether people stick to their inhaler plans.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.